India’s government-backed vaccination programme has largely been powered by two vaccines – Covishield (developed by AstraZeneca and manufactured by the Serum Institute of India) and Covaxin (a domestically-developed jab yet to be approved by WHO). Throughout September, India was administering an average of 7.9 million vaccine doses daily.